Evolution of the Average Target: Glenmark Pharmaceuticals Limited

Evolution of the Average Target - Glenmark Pharmaceuticals Limited

Evolution of the Target Price: Glenmark Pharmaceuticals Limited

Evolution of the Target Price - Glenmark Pharmaceuticals Limited

Changes in Analyst Recommendations: Glenmark Pharmaceuticals Limited

882e9fff25ec6.TGe4sZwuX_mNWucuXyIQ-1SEE8h7sK9508RiDDCKsI4.PjGI0P95bIzkELVrGBFhgxXsYqYa99wjn5UsY0bI5esaFdDp70Mr1P93og~4f70b661d3923dddcdc544d37a45ce29

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+1.01%
+2.58%
-1.11%
+6.64%
-3.15%
+11.81%
-4.82%
+16.44%
-6.38%
+4.98%
Average +2.80%
Weighted average by Cap. +2.73%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
2,632.90INR
Average target price
2,659.55INR
Spread / Average Target
+1.01%
High Price Target
3,069.00INR
Spread / Highest target
+16.56%
Low Price Target
2,100.00INR
Spread / Lowest Target
-20.24%

Analyst Consensus Detail

Analyst consensus - Glenmark Pharmaceuticals Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Glenmark Pharmaceuticals Limited
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Glenmark Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. GLENMARK Stock
  4. Consensus Glenmark Pharmaceuticals Limited